Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012. - Wikidata - awgldk - TriplyDB

Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

http://www.wikidata.org/entity/Q30773209

about

Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.An explorative study of school performance and antipsychotic medication Influence of socioeconomic status on antipsychotic prescriptions among youth in France Psychopharmacological Prescriptions in Children and Adolescents in Germany ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.Atypical antipsychotics for disruptive behaviour disorders in children and youths.Delayed yet persistent effects of daily risperidone on activity in developing rats.A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012 Psychotropic medication in children and adolescents.Turning children into psychiatric patients.More patients in less time Administering shortages.Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.Early-life risperidone enhances locomotor responses to amphetamine during adulthood.Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland.

P2860

Q35907700-BDF84FFE-7EBF-4C0F-959E-3405C6083B67 Q36140101-03E585B3-2AD8-431E-9E58-9605DC25E2F7 Q36292249-B22F0E6E-B587-4817-BD8B-8EFF78644BA1 Q37067376-3C101593-4C4A-4F62-8DA6-B676BF0DBCB2 Q37736303-CE53C2C4-5C22-421D-A125-FB9087CDA367 Q38632745-94EA7994-2302-4177-94C5-42C32F1F105A Q41817162-F47D74A2-CFF8-471D-99AB-8CFAC316F961 Q42375282-E0DAECC1-7369-410E-A67B-2F901A044691 Q42413463-E6FB0588-B8DB-4FA8-B586-1A1456982B09 Q42554053-1C56A2BD-52F6-4EA4-88A8-D76E73D04967 Q42643584-F67A6FB9-F67C-41E1-B7E2-7047522F27E7 Q42643594-025CDA30-D907-408B-9F36-99FF97B525DF Q47307661-BB6887C9-162B-466F-8EB6-0BAE14B19322 Q54466329-CE3D487F-88AE-4C05-9951-AF4F50C34199 Q55283481-AC03A9BB-8AD0-4FE6-9B55-61D8FA7D0F87

P2860

Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

http://www.wikidata.org/entity/Q30773209

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@ast

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@en

type

label

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@ast

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@en

prefLabel

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@ast

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@en

P1433

Q30773209-51D9BB00-1544-470E-B7D9-13AC5E8A03DE

P1476

Q30773209-6754D05D-530A-402C-AB94-444AE9B1F934

P2093

Q30773209-1716B117-1EC6-4AB9-9304-A4ACE8933AA0

Q30773209-468A46EC-4E33-45B0-A937-D52876771E00

Q30773209-DB5E483A-40FC-4625-9877-79298C56CC27

P2860

Q30773209-0527ADAC-73EB-427F-84D6-14CB68423602

Q30773209-06CE2BBC-D353-4F9E-A910-63A4AC3487F6

Q30773209-11365213-BD4F-4B8D-8AEB-34D11304CA25

Q30773209-1258F19B-F7D1-4CDE-B581-83EA368CF549

Q30773209-16CBA460-7FD3-4DDE-976D-E3994A967E36

Q30773209-1FA29ED0-9439-4EBC-8065-5DE91D1E1D7C

Q30773209-3DAC28B7-CF61-46EB-8070-A9A229F63473

Q30773209-3F8204CF-8001-4B15-8FF4-F647FE7312FC

Q30773209-442C49D7-3E33-4898-98A3-F10721545A87

Q30773209-4BB79094-C6DF-417E-A8BB-79EDA6D07520

P304

Q30773209-77228B9D-00A9-4BCC-A307-17AE9C60CCDA

P31

Q30773209-75E3DE32-06DA-4DDE-ACCA-13D10840BDE6

P356

Q30773209-B3A36BD0-5B04-4449-9EF3-CD029AF6E7FD

P433

Q30773209-8F38EAA7-5F46-4115-9E10-485A0A4F377C

P478

Q30773209-D9015735-B518-477F-B210-FEAE40D5E650

P50

Q30773209-FE067085-BB62-4331-ABC6-5509373DD193

P577

Q30773209-8E91F709-2242-4C32-970C-6FAB8B8FE5EB

P5875

Q30773209-B0A0E608-71A9-43DB-B410-B565C4A0C280

P698

Q30773209-83106792-5D4A-4060-A731-B11CA97C1585

P921

Q30773209-DCB31239-6345-4B2A-9D57-FB0CC449DCEF

P932

Q30773209-717BB37A-B39D-4E71-867B-193B5EFD7F5C

P356

ARZTEBL.2014.0025

P1433

Deutsches Ärzteblatt international

P1476

Antipsychotic prescription in ...... nce company from 2005 to 2012.

@en

P2093

Christian J Bachmann

http://www.w3.org/2001/XMLSchema#string

Gerd Glaeske

http://www.w3.org/2001/XMLSchema#string

Thomas Lempp

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical antipsychotics for disruptive behaviour disorders in children and youths

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints

Prevalence and comorbidities of adolescent depression in Germany. An analysis of Health Insurance Data.

Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data

Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database.

Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data.

The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Antidepressant and antipsychotic use in an Italian pediatric population.

P304

25-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2014.0025

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260644276

http://www.w3.org/2001/XMLSchema#string

P698

24606780

http://www.w3.org/2001/XMLSchema#string

P921

P932

3950759

http://www.w3.org/2001/XMLSchema#string